The Technical Analyst
SomaLogic, Inc. [SLGC]
Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
SomaLogic, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
-4.55% $2.10
America/New_York / 5 jan 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 396.23 mill |
| EPS: | -0.690 |
| P/E: | -3.04 |
| Earnings Date: | Mar 26, 2024 |
| SharesOutstanding: | 188.68 mill |
| Avg Daily Volume: | 2.27 mill |
| RATING 2024-01-05 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Neutral | |
| P/E: | Strong Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a | n/a | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -3.04 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -3.04 | industry: PE -4.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 1.933 - 2.27 ( +/- 7.95%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-05 | Taich Adam | Sell | 48 425 | Common Stock |
| 2024-01-05 | Taich Adam | Sell | 185 812 | Stock Option (Right to buy) |
| 2024-01-05 | Taich Adam | Sell | 110 000 | Stock Option (Right to buy) |
| 2024-01-05 | Taich Adam | Sell | 145 000 | Stock Option (Right to buy) |
| 2024-01-05 | Taich Adam | Sell | 150 000 | Stock Option (Right to buy) |
| INSIDER POWER |
|---|
| -85.45 |
| Last 95 transactions |
| Buy: 2 347 082 | Sell: 20 640 281 |
Forecast:
01:40 - $2.49
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $2.10 (-4.55% ) |
| Volume | 33.91 mill |
| Avg. Vol. | 2.27 mill |
| % of Avg. Vol | 1 494.88 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For SLGC
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
SLGC
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal research use only and laboratory-developed tests. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions, as well as facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.
Latest Press Releases
2024-01-04 21:44:00 - Press Release
Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Stockholder approval represents key milestone toward completion of standard biotools transaction combination will create a diversified leader in life sciences tools boulder, colo. , jan. 4, 2024 /prnewswire/ -- somalogic, inc. (nasdaq: slgc) ("the company"), a leader in proteomics technology, today announced that, based on the preliminary vote count provided by its proxy solicitors following the company's special meeting of stockholders (the "special meeting") held earlier today, somalogic stockholders voted to approve the transaction with standard biotools inc. (nasdaq: lab) ("standard biotools").
2024-01-04 18:57:00 - Press Release
Madryn Asset Management Demands Somalogic's Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
New york--(business wire)--madryn asset management, lp (collectively with its affiliates, “madryn” or “we”), a holder of approximately 4.2% of the outstanding common stock of somalogic, inc. (“somalogic” or the “company”) (nasdaq: slgc), is demanding the company finally answer key questions related to its repeated adjournments of the special meeting of shareholders (the “special meeting”) pertaining to the proposed merger (the “proposed merger” or the “transaction”) with standard biotools inc.
2024-01-04 14:23:00 - Press Release
Madryn Asset Management Addresses Somalogic's Apparent Failure To Obtain Requisite Shareholder Support For The Proposed Merger With Standard Biotools
New york--(business wire)--madryn asset management, lp (collectively with its affiliates, “madryn” or “we”), a holder of approximately 4.2% of the outstanding common stock of somalogic, inc. (“somalogic” or the “company”) (nasdaq: slgc), today issued the below statement regarding today's multiple adjournments of the special meeting of shareholders (the “special meeting”) related to the proposed merger (the “proposed merger” or the “transaction”) with standard biotools inc. (“standard biotools”).
2024-01-02 08:00:00 - Press Release
Somalogic Urges Stockholders To Maximize Value Of Their Investment By Voting "for" Pending Merger With Standard Biotools
Leading independent proxy advisory firms iss and glass lewis both recommend somalogic stockholders vote "for" proposed merger with standard biotools boulder, colo. , jan. 2, 2024 /prnewswire/ -- somalogic, inc. (nasdaq: slgc) ("the company"), a leader in proteomics technology, today sent the following open letter to stockholders urging them to vote "for" the value maximizing transaction with standard biotools.
2023-12-31 14:10:00 - Press Release
Boston Millennia Partners Intends To Vote Against Proposed Merger Of Somalogic With Standard Biotools
Boston--(business wire)--boston millennia partners (“boston millennia”), a significant shareholder of somalogic (the “company”) (nasdaq: slgc) today announced that it intends to vote against the company's planned merger (the “merger”) with standard biotools inc. (nasdaq: lab).
Latest News
2023-11-10 13:34:05 - Seeking Alpha
SomaLogic Inc. (SLGC) Q3 2023 Earnings Call Transcript
SomaLogic Inc. (NASDAQ:SLGC ) Q3 2023 Results Conference Call November 8, 2023 4:30 PM ET Company Participants Noah Corin - IR, Gilmartin Group Adam Taich - Interim CEO Eliot Lurier - Interim Chief Financial Officer Conference Call Participants Kyle Mikson - Canaccord Genuity Kyle Boucher - TD Cowen Operator Good afternoon, and welcome to SomaLogic's Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
2023-10-31 16:30:00 - GlobeNewsWire
SomaLogic to Announce Third Quarter 2023 Financial Results on November 8, 2023
BOULDER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the third quarter 2023 after market close on November 8, 2023. Management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
2023-10-04 18:49:14 - The Motley Fool
Why SomaLogic Stock Dived by 10% on Wednesday
It is merging with a peer in the next-generation medical tech field. This will be effected entirely in stock.
2023-10-04 08:36:00 - Market Watch
SomaLogic's stock surges as it agrees to be bought by Standard BioTools in all-stock merger
SomaLogic Inc.'s SLGC, -2.54% stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with Standard BioTools LAB, -1.10% valued at about $1 billion.
2023-09-22 05:50:00 - The Motley Fool
3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too
Beam Therapeutics is pioneering a promising type of gene editing. Recursion Pharmaceuticals is harnessing AI to improve drug discovery.
2023-08-15 12:52:38 - The Motley Fool
Why Shares of SomaLogic Are Up Tuesday
SomaLogic makes life sciences tools. The company said it plans a launch of its SomaScan assay this year.
2023-08-14 20:11:09 - Seeking Alpha
Somalogic, Inc. (SLGC) Q2 2023 Earnings Call Transcript
Somalogic, Inc. (NASDAQ:SLGC ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Marissa Bych - Group Investor Relations Adam Taich - Interim CEO Eliot Lurier - Interim CFO Conference Call Participants Kyle Mikson - Canaccord Genuity Daniel Brennan - TD Cowen Daniel Arias - Stifel, Nicolaus & Company Brandon Couillard - Jefferies Operator Good afternoon, and welcome to SomaLogic's Second Quarter 2023 Earnings Conference Call. [Operator Instructions].
2023-07-24 16:30:00 - GlobeNewsWire
SomaLogic to Announce Second Quarter 2023 Financial Results on August 14, 2023
BOULDER, Colo., July 24, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the second quarter 2023 after market close on August 14th, 2023. Management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
2023-06-07 11:03:20 - Zacks Investment Research
SomaLogic, Inc. (SLGC) Just Flashed Golden Cross Signal: Do You Buy?
SomaLogic, Inc. (SLGC) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, SLGC's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross.
2023-05-11 21:50:30 - Seeking Alpha
SomaLogic, Inc. (SLGC) Q1 2023 Earnings Call Transcript
SomaLogic, Inc. (NASDAQ:SLGC ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relations, Gilmartin Group LLC Adam Taich - Chief Executive Officer Shaun Blakeman - Chief Financial Officer Conference Call Participants Daniel Brennan - TD Cowen Dan Arias - Stifel Financial Corp. Kyle Mikson - Canaccord Genuity Group Inc. Brandon Couillard - Jefferies Group LLC Operator Good afternoon, and welcome to SomaLogic's First Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.